Clinical Trials in Spain / NCT06932120
Recruiting Not applicable

Technology-supported Interventions for Prolonged Grief Disorder (PGD)

NCT06932120 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2025-11-10
Last updated
2026-01-21

Condition(s) studied

Prolonged Grief Disorder (PGD)

Investigational drug(s) / intervention(s)

Internet-based treatment (GROw) combined with face-to-face videoconferencing sessions with a therapist in BF-GROw groupInternet-based treatment (GROw) supported by the App developed which contains the EMA and EMI tools in iGROw group.

Internet-based treatment (GROw) combined with face-to-face videoconferencing sessions with a therapist in BF-GROw group: The treatment that will be applied is an internet-based treatment (GROw) (Tur et al., 2021, 2022)combined with face-to-face videoconferencing sessions with a therapist (blended) . This protocol has 8 weekly modules and lasts between 8 and 12 weeks. The modules included are: 1) Welcome (starting the program), 2) Understanding reactions to loss, 3) Coping with loss, 4) Loss integration and restoration (first steps), 5) Deeping integration and restoration of loss, 6) Consolidating loss integration and restoration, 7) Self-care, guilt, and forgiveness in the grieving process, and 8) Evaluating progress and looking to the future. BF-GROw group will receive a treatment module every 10-12 days. This protocol is available online: (https://psicologiaytecnologia.labpsitec.es).

Internet-based treatment (GROw) supported by the App developed which contains the EMA and EMI tools in iGROw group.: The treatment that will be applied is an internet-based treatment (GROw) (Tur et al., 2021, 2022) supported by the App developed which contains the Ecological Momentary Assessment (EMA) and Ecological Momentary Intervention (EMI) tools . This protocol has 8 weekly modules and lasts between 8 and 12 weeks. The modules included are: 1) Welcome (starting the program), 2) Understanding reactions to loss, 3) Coping with loss, 4) Loss integration and restoration (first steps), 5) Deeping integration and restoration of loss, 6) Consolidating loss integration and restoration, 7) Self-care, guilt, and forgiveness in the grieving process, and 8) Evaluating progress and looking to the future. This protocol is available online: (https://psicologiaytecnologia.labpsitec.es).

Study summary

The main aim of this project is to test the efficacy of two formats of delivering an internet- based treatment(GROw) for Prolonged Grief Disorder (PGD) in order to enhance treatment adherence: in a blended format (that combines self-applied treatment online with face-to face sessions with a therapist by videoconference: BF-GROw) and self-applied online format supported by Ecological Momentary Assessment (EMAs) and Ecological Momentary Interventions (EMIs) (iGROw), compared with a waiting list (WL) control group in a community sample of patients with the diagnosis of PGD. The general initial hypothesis is that both treatment conditions (blended format and self-applied format supported by EMAs and EMIs) will significantly produce an improvement in grief symptoms, compared to the WL control group.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Being at least 18 years old. * Meeting diagnostic criteria for Prolonged Grieft Disorder based on the International Classification of Diseases 11 edition (ICD-11). * Sign an informed consent. * Ability to understand and read Spanish. * Ability to use a computer. * Having an e-mail address. * Having an internet connection and Access to a Smartphone. Exclusion Criteria: * Presence of high risk of suicide. * Presence of axis I severe mental disorder: substance abuse or dependence, psychotic disorder, dementia, bipolar disorder; severe personality disorder or medical illness whose severity or characteristics prevent treatment. * Receiving other psychological treatment during the study. * An increase and/or change in the medication during the study period, in the case of receiving pharmacological treatment.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Universitat Jaume I Castellon Castellón de La Plana Recruiting
Universitat Jaume I Castellon Castellón Not Yet Recruiting

More Universitat Jaume I trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06932120 on ClinicalTrials.gov ↗ ← All trials in Spain